WHO Raises Warning Over Severe Scarcity of Weight-Loss Medications

Less than a tenth of patients that would benefit from obesity jabs like Wegovy are able to get them, warns the global health agency as it issues its inaugural guidance on the medications.

With in excess of 1,000,000,000 individuals worldwide currently classified as obese, it is urging broader and more equitable access to this class of drugs.

According to estimates, in excess of 2,000,000,000 are projected to be obese by 2030 without intervention.

"Our new guidelines acknowledges that excess weight is a chronic disease that can be managed with holistic and continuous treatment," stated the agency's head Tedros Adhanom Ghebreyesus.

Significant expense, insufficient output, and logistical bottlenecks are key hurdles to universal access to the jabs that can assist patients in reducing considerable body mass, says the agency.

Weight-Loss Drug Supply Crisis

Even in the present most optimistic outlook, the manufacturing of these medications could only cover around 100 million people – under 10% of eligible patients, per the health organization.

The guideline calls on countries and companies to widen availability, through approaches like patent sharing.

The intellectual property rights on the active ingredient – the primary component of a leading brand – is scheduled to end in a number of nations in 2026.

The Way Obesity Injections Function

The injections replicate a natural hormone to reduce digestion speed, suppress the appetite and boost satiety so users consume fewer calories.

Individuals usually see weight reduction in the initial weeks of beginning the regular doses.

Evidence points to patients may regain a significant portion within a year of stopping the medication, when their typical hunger return.

To be above a healthy weight elevates your risk for developing diseases, such as type 2 diabetes, heart disease, brain attack, and specific malignancies.

Excess weight impacts individuals in every country and was linked to millions of fatalities worldwide in 2024, per the health agency.